Please assess the completion status of the following clinical trial:

Trial Title: MEDTRUM A7+ TouchCare Insulin Patch Pump (MedInPS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with type 1 or 2 diabetes, 18 years of age and over~* Patients already equipped with Omnipod® ® (INSULET) insulin patch pump and Abbott FreeStyleLibre sensor®.~* A1C ranking from : \>= 6,5% to \<= 9.5%~* Any type of rapid insulin except FIASP (which can be substituted if necessary) with 60 IU max per day (unauthorized use of insulin supplements by pen injector)~* Patient able to receive and understand study information, give written informed consent, and easily participate to the trial~* Patient affiliated to the French social security system~Exclusion Criteria:~* - Patient already participating in another study~* Patient under the protection of justice or under guardianship or curatorship~* Type 2 diabetic patient requiring a daily insulin dose \> 60 IU~* Patients not suitable for suing insulin pump such as: severe psychiatric disorders, rapidly progressing ischemic or proliferative retinopathy before laser treatment, and exposure to high magnetic ﬁelds~* Patients allergic to nickel and adhesive~* Pregnant women, breastfeeding women~* Or any other criteria as appreciated by the study investigator.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active Group (Type: EXPERIMENTAL): Using the Medtrum Pump A7+ during 3 months
- Control Group (Type: ACTIVE_COMPARATOR): using the usual Insulet Patch pump

Based on this trial design, predict the completion outcome and termination type (if applicable).